LAMEA Pneumonia Vaccines Market By Vaccine Type (Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV)), By Product Type (Prevnar 13, Synflorix and Pneumovax23), By sector (Public sector and Private sector), By Distribution Channel (Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pneumonia Vaccines Market, by Vaccine Type
1.4.2 LAMEA Pneumonia Vaccines Market, by Product Type
1.4.3 LAMEA Pneumonia Vaccines Market, by Sector
1.4.4 LAMEA Pneumonia Vaccines Market, by Distribution Channel
1.4.5 LAMEA Pneumonia Vaccines Market, by Region
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Pneumonia Vaccines Market by Vaccine Type
3.1 LAMEA Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 LAMEA Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
Chapter 4. LAMEA Pneumonia Vaccines Market by Product Type
4.1 LAMEA Prevnar 13 Market by Region
4.2 LAMEA Synflorix Market by Region
4.3 LAMEA Pneumovax 23 Market by Region
Chapter 5. LAMEA Pneumonia Vaccines Market by Sector
5.1 LAMEA Private sector Market by Region
5.2 LAMEA Public sector Market by Region
Chapter 6. LAMEA Pneumonia Vaccines Market by Distribution Channel
6.1 LAMEA Distribution Partner Companies Market by Region
6.2 LAMEA Non-Governmental Organizations (NGO) Market by Region
6.3 LAMEA Government Authorities Market by Region
Chapter 7. LAMEA Pneumonia Vaccines Market by Region
7.1 Brazil Pneumonia Vaccines Market
7.1.1 Brazil Pneumonia Vaccines Market by Vaccine Type
7.1.2 Brazil Pneumonia Vaccines Market by Product Type
7.1.3 Brazil Pneumonia Vaccines Market by Sector
7.1.4 Brazil Pneumonia Vaccines Market by Distribution Channel
7.2 Argentina Pneumonia Vaccines Market
7.2.1 Argentina Pneumonia Vaccines Market by Vaccine Type
7.2.2 Argentina Pneumonia Vaccines Market by Product Type
7.2.3 Argentina Pneumonia Vaccines Market by Sector
7.2.4 Argentina Pneumonia Vaccines Market by Distribution Channel
7.3 UAE Pneumonia Vaccines Market
7.3.1 UAE Pneumonia Vaccines Market by Vaccine Type
7.3.2 UAE Pneumonia Vaccines Market by Product Type
7.3.3 UAE Pneumonia Vaccines Market by Sector
7.3.4 UAE Pneumonia Vaccines Market by Distribution Channel
7.4 Saudi Arabia Pneumonia Vaccines Market
7.4.1 Saudi Arabia Pneumonia Vaccines Market by Vaccine Type
7.4.2 Saudi Arabia Pneumonia Vaccines Market by Product Type
7.4.3 Saudi Arabia Pneumonia Vaccines Market by Sector
7.4.4 Saudi Arabia Pneumonia Vaccines Market by Distribution Channel
7.5 South Africa Pneumonia Vaccines Market
7.5.1 South Africa Pneumonia Vaccines Market by Vaccine Type
7.5.2 South Africa Pneumonia Vaccines Market by Product Type
7.5.3 South Africa Pneumonia Vaccines Market by Sector
7.5.4 South Africa Pneumonia Vaccines Market by Distribution Channel
7.6 Nigeria Pneumonia Vaccines Market
7.6.1 Nigeria Pneumonia Vaccines Market by Vaccine Type
7.6.2 Nigeria Pneumonia Vaccines Market by Product Type
7.6.3 Nigeria Pneumonia Vaccines Market by Sector
7.6.4 Nigeria Pneumonia Vaccines Market by Distribution Channel
7.7 Rest of LAMEA Pneumonia Vaccines Market
7.7.1 Rest of LAMEA Pneumonia Vaccines Market by Vaccine Type
7.7.2 Rest of LAMEA Pneumonia Vaccines Market by Product Type
7.7.3 Rest of LAMEA Pneumonia Vaccines Market by Sector
7.7.4 Rest of LAMEA Pneumonia Vaccines Market by Distribution Channel
Chapter 8. Company Profiles
8.1 GLAXOSMITHKLINE PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Collaboration, partnerships and agreements:
8.1.1.2 Expansion:
8.1.2 SWOT Analysis
8.2 LG Corporation (LG Chemicals Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Panacea Biotec Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Collaboration, partnerships and agreements:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Collaboration, partnerships and agreements:
8.4.5.2 Product launch:
8.4.6 SWOT Analysis
8.5 PnuVax Incorporated
8.5.1 Company Overview
8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
8.6.1 Company Overview
8.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
8.7.1 Company Overview
8.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
8.8.1 Company overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.9 Walvax Biotechnology Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product launch:
8.1 Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Collaboration, partnerships and agreements:
8.10.5.2 Product launch:
8.10.6 SWOT Analysis